525.2K
Downloads
379
Episodes
The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight
Episodes
3 days ago
3 days ago
1 hr 25 min
Why do some people experience incredible results from peptides while others barely notice a difference?
In this episode of The Energy Code, Dr. Mike Belkowski and Don Bailey explore one of the most overlooked concepts in peptide science: mitochondrial health may determine how well your body responds to peptide signaling.
The conversation dives into why healthy mitochondria provide the energy required for peptide signaling, how inflammation and oxidative stress can reduce peptide sensitivity, and why optimizing cellular energy may improve the effectiveness of both your body's own peptides and therapeutic peptides like Retatrutide, BPC-157, GLP-1s, and more.
They also discuss Don's personal Retatrutide journey, microdosing strategies, preserving muscle during weight loss, insulin resistance, GLP-1 biology, HRV changes, receptor signaling, ATP production, oxidative stress, and why improving mitochondrial function could become one of the most important ways to maximize peptide outcomes.
If you're interested in peptides, longevity, metabolism, or mitochondrial health, this episode connects these topics in a way you've probably never heard before.
(Educational content only, not medical advice.)
-
Key Quotes From Dr. Mike:
"Mitochondrial dysfunction may be one of the biggest reasons people respond differently to peptides."
"The better your mitochondria function, the better your body can respond to both endogenous and therapeutic peptides."
"A peptide can bind perfectly to its receptor and still fail if the cell doesn't have the energy to respond."
"The downstream response to a peptide is incredibly energy intensive."
(In regards to weight loss): "Lose the inflammation, improve the mitochondria, improve peptide sensitivity."
"The goal isn't the highest peptide dose. It's the greatest response from the lowest effective dose."
"Retatrutide should be viewed as a long-term metabolic tool — not a race to lose weight."
"Improving mitochondria may be one of the most overlooked ways to maximize peptide therapy."
-
Key Points
⚡ Mitochondrial health may be one of the biggest factors determining how effectively your body responds to peptides.
⚡ Peptides don't work in isolation—they require healthy, energy-producing cells to generate their full biological response.
⚡ ATP produced by mitochondria powers the downstream signaling that allows peptides to carry out their functions.
⚡ Mitochondrial dysfunction may reduce peptide sensitivity, even when receptors and peptide levels are normal.
⚡ Inflammation and oxidative stress can create "cellular noise" that interferes with peptide signaling pathways.
⚡ Insulin resistance is a real-world example of peptide resistance, demonstrating how poor metabolic health can impair cellular communication.
⚡ Improving mitochondrial function may enhance both your body's naturally produced peptides and therapeutic peptides.
⚡ Losing excess body fat can improve mitochondrial function, reduce inflammation, and restore healthier peptide signaling.
⚡ GLP-1 medications like Retatrutide may work even better when combined with strategies that optimize mitochondrial health.
⚡ Microdosing peptides may produce excellent results when cellular bioenergetics are optimized, reducing the need for higher doses.
⚡ Peptide signaling requires far more than receptor binding—it depends on energy-intensive intracellular processes driven by healthy mitochondria.
⚡ Healthy mitochondria help cells respond more efficiently to repair, growth, metabolic, and anti-inflammatory peptide signals.
⚡ The discussion highlights why two people taking the same peptide can experience dramatically different outcomes.
⚡ Optimizing mitochondrial function through nutrition, exercise, red light therapy, sleep, and metabolic health may improve peptide responsiveness.
⚡ The future of peptide medicine may involve treating mitochondrial dysfunction first to maximize the effectiveness of peptide therapies.
-
Episode timeline
00:00 — Welcome Back & Don's Retatrutide Experience
03:00 — Losing Weight Without Losing Muscle
06:15 — Why Fat Creates Mitochondrial Dysfunction
08:20 — Why Your Body Needs More Than Natural GLP-1
11:20 — GLP-1s Beyond Weight Loss
13:00 — Retatrutide Side Effects & Real-World Experience
17:00 — Why We Microdose Retatrutide
20:45 — GLP-1 vs Tirzepatide vs Retatrutide
22:00 — HRV, Heart Rate & Retatrutide
25:00 — What Is Peptide Sensitivity?
28:30 — ATP: The Missing Piece of Peptide Signaling
30:30 — Mitochondrial Dysfunction Creates Peptide Resistance
33:00 — Oxidative Stress, Redox & Cellular Noise
35:30 — What Sparked This Entire Conversation
37:45 — Receptor Trafficking & Why Mitochondria Matter
-
Research Use Only Peptides
Both injectables & nasal spray solutions
High purity. High sterility. Low endotoxin. Verified through rigorous quality testing.
Explore Peptides → BioLight Labs
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight Labs:
BioLight:
Sep 17, 2026
Sep 17, 2026
34 min
The peptide landscape is evolving faster than ever before — and 2026 may prove to be the biggest turning point yet.
In this episode, Dr. Mike Belkowski breaks down the most important developments shaping the future of peptide science, longevity, metabolism, and mitochondrial medicine.
From major FDA regulatory changes and groundbreaking clinical trials to the next generation of GLP-1 drugs, mitochondrial peptides, amylin agonists, oral peptide therapeutics, and the latest pharmaceutical breakthroughs, this episode explores where peptide medicine is headed over the next several years.
You'll also hear why MOTS-c may be transitioning from a "biohacker peptide" into legitimate clinical medicine, why SS-31 represents a milestone for mitochondrial therapeutics, why retatrutide continues to redefine metabolic medicine, and which peptide trends deserve your attention moving forward.
If you're interested in longevity, mitochondrial health, bioenergetics, metabolic optimization, or simply want to stay ahead of one of the fastest-moving fields in medicine, this episode is your comprehensive update.
(Educational content only, not medical advice.)
-
Key Quotes From Dr. Mike:
"The committee wasn't voting on whether these peptides work. They were voting on whether licensed compounding pharmacies should be allowed to prepare them."
"Retatrutide is rapidly evolving from a weight-loss drug into a multi-system metabolic therapeutic."
"Mitochondrial-targeted peptide therapy is becoming a legitimate therapeutic category."
"MOTS-c is becoming one of the first true biohacker peptides to enter legitimate pharmaceutical research."
"SS-31 is no longer theoretical — mitochondrial peptide therapy is now a clinical reality."
"Intranasal mitochondrial peptides may have enormous future potential for brain health."
"Amylin may become wave three of metabolic medicine."
"Developers are now targeting energy expenditure, liver metabolism, adipose biology, and insulin signaling simultaneously."
"Oral peptide therapeutics may become one of the biggest pharmaceutical revolutions of the next decade."
"Peptides are one of the most exciting frontiers in health, longevity, and human energy."
-
Key Points
⚡ 2026 is becoming a landmark year for peptide science, regulation, and clinical development.
⚡ Four new BioLight Labs intranasal peptides were announced: MOTS-c, MOTS-c + SS-31, Oxytocin, and BPC-157.
⚡ The FDA's Pharmacy Compounding Advisory Committee recommended six peptides for potential future 503A compounding inclusion while rejecting DSIP.
⚡ Those FDA recommendations are advisory—not approvals—and formal rulemaking is still required.
⚡ Retatrutide continues to produce unprecedented weight-loss results approaching bariatric surgery outcomes.
⚡ GLP-1 therapies are evolving beyond weight loss into treatments for metabolic disease, sleep apnea, osteoarthritis, and other chronic conditions.
⚡ Amylin peptides are emerging as the next major frontier in obesity and metabolic medicine.
⚡ Petrelintide demonstrated impressive weight loss with placebo-like gastrointestinal tolerability.
⚡ Novo Nordisk's dual GLP-1/amylin peptide is advancing rapidly through clinical development.
⚡ MOTS-c has entered a randomized Phase 2 clinical trial, representing a major milestone for mitochondrial peptides.
⚡ MOTS-c is becoming one of the first "biohacker peptides" to transition into rigorous pharmaceutical research.
⚡ SS-31 (Elamipretide) became an FDA-approved mitochondrial-targeted peptide therapy for Barth syndrome.
⚡ Mitochondrial peptides are rapidly evolving from experimental longevity compounds into legitimate therapeutic candidates.
⚡ Dr. David Perlmutter's new book highlights mitochondrial health as a critical determinant of microglial function and brain health.
⚡ Intranasal mitochondrial peptides may eventually become promising tools for brain injury, stroke recovery, and neurodegeneration.
⚡ Servodutide is showing remarkable promise for fatty liver disease and obesity.
⚡ Pemvidutide produced encouraging Phase 2 results for alcohol use disorder.
⚡ Oral macrocyclic peptides are transforming peptide drug development by eliminating the need for injections.
⚡ Regulatory momentum around peptides continues to accelerate faster than human clinical evidence.
⚡ The peptide field is splitting into two worlds: highly engineered pharmaceutical drugs and early-stage regenerative peptides.
⚡ Curiosity should always be balanced with scientific evidence, safety, and quality.
-
Episode timeline
00:00 — Introduction & New BioLight Labs Intranasal Peptides
04:14 — FDA Peptide Regulatory Update
07:01 — Retatrutide Continues to Impress
08:44 — Amylin: The Next Metabolic Frontier
11:39 — MOTS-c Enters Phase 2 Clinical Trials
12:55 — Humanin, SHLPs & SS-31
14:47 — Brain Health, Microglia & Dr. David Perlmutter
18:48 — Servodutide & Fatty Liver Disease
19:55 — Pemvidutide & Addiction Research
21:35 — The Rise of Oral Peptides
22:57 — BPC-157, TB-500 & KPV: Regulatory Momentum vs Clinical Evidence
24:16 — FDA Preparing for the Generic GLP-1 Era
25:47 — Eight Peptide Trends to Watch
30:38 — Final Takeaways & The Future of Peptide Medicine
-
Research Use Only Peptides
Both injectables & nasal spray solutions
High purity. High sterility. Low endotoxin. Verified through rigorous quality testing.
Explore Peptides → BioLight Labs
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight Labs:
BioLight:
Sep 10, 2026
Sep 10, 2026
1 hr 13 min
In this special episode of The Energy Code, Dr. Mike Belkowski sits down with Jarrod Barakett, President of The Light System, to explore the intersection of light frequencies, bioenergetics, cellular energy, and human performance.
Jarrod shares his deeply personal journey into frequency medicine, including how a severe spinal injury and emergency surgery led him to discover The Light System and the technology he credits with dramatically accelerating his recovery.
Together, they explore the history and concepts behind The Light System, a technology originally developed by inventor Robert J. that uses coded affirmations, sacred geometry, and polychromatic light frequencies. Jarrod explains the system’s theories around cellular water, electrical voltage, energy flow, and the body’s ability to recover and adapt.
The conversation covers everything from bio-photonic collisions and water restructuring to EMF-mitigating technology, quantum-charged vessels, cellular voltage, mindset, and the potential relationship between energy flow and human resilience.
Educational content only. This episode is not medical advice.
🔥 In This Episode
• Jarrod Barakett’s journey into frequency medicine and his recovery from a severe spinal injury
• The history and origins of The Light System
• Sacred geometry and its role in frequency-based technologies
• How water may interact with frequency, words, and intention
• Polychromatic light and bio-photonic collisions
• Cellular electrical charge and the concept of “cellular voltage”
• Environmental stressors including Bluetooth, Wi-Fi, and processed foods
• Buccal cell testing and measurements of electrical conductivity
• Quantum-charged water bottles, jewelry, and other products
• The Light System’s approach to EMF exposure
• Mental clarity, emotional resilience, grief, and energy flow
• The placebo effect and the connection between mindset and physiology
• Sunlight, frequency, peptides, and the future of medicine
💡 Key Takeaways
• Jarrod’s personal recovery experience was a major catalyst for his interest in frequency medicine.
• The Light System was developed around the concept of delivering coded affirmations through specific light frequencies.
• The technology incorporates concepts including sacred geometry, polychromatic light, and frequency-based interactions with water.
• Jarrod discusses the theory that restructuring cellular water may influence energy flow throughout the body.
• Hybrid Light System units use opposing monitors to create what Jarrod describes as bio-photonic collisions and an associated energy field.
• The conversation explores the idea that modern environmental factors may affect the body’s electrical charge and energy balance.
• Jarrod discusses testing involving buccal cells that he says demonstrated measurable changes in cellular electrical conductivity.
• Quantum-imprinted copper vessels are discussed as a way of transferring energy to drinking water.
• The Light System smartwatch incorporates a quantum-charged stainless-steel band and coded affirmations.
• The episode explores the relationship between mindset, intention, the placebo effect, and physiological responses.
🎙️ Key Quotes from Jarrod Barakett
“Everything around us is made up of frequency… those frequencies exist, whether heard or not heard.”
“By restructuring the water within our bodies, we are restructuring the energy flow within our body.”
“When those photons leave each opposing monitor, they collide right in the center… and that collision creates a burst of energy.”
“Instead of replenishing our energy tank through food… we need to expel more energy to get toxins out.”
“If we can free up those blockages or make the flow of energy more efficient… then our body will be in a better place.”
“We are giving the body more tools… elevating the electrical charge so the body is in a better place to do what it knows how to do.”
“The mind is that powerful that if it truly believes something, then your body will follow.”
⏱️ Episode Timeline
00:00:00 — Introduction to The Energy Code & Jarrod Barakett
00:01:56 — Jarrod’s Background: Mindset, Agronomy & Cannabis Industry
00:03:46 — Severe Spinal Injury & Rapid 10-Week Recovery
00:07:50 — History & Origins of The Light System
00:10:39 — Mindset, Business Leadership & Energetic Principles
00:11:08 — Mid-Roll: Methylene Blue & Bio Blue Promotion
00:14:56 — Sacred Geometry, Spheres & Cubes
00:16:30 — Cellular Water, Frequency & Words
00:20:06 — Restructuring Energy Flow & Cellular Blockages
00:23:12 — Polychromatic Therapy & Bio-Photonic Collisions
00:26:06 — Cellular Voltage & Modern Environmental Toxins
00:30:49 — Jarrod’s Unconventional Recovery & Surgeon’s Reaction
00:34:31 — Buccal Cell Electrical Conductivity Research
00:36:03 — Quantum-Charged Water Bottles & Jewelry
00:37:39 — EMF Protection & The Quantum Smartwatch
00:43:11 — Testimonials & Real-World Experiences
00:44:36 — Product Breakdown: Pyramid Mini, Cubes & Dual-Cube Setups
00:47:08 — Product Placement: Garages, Bedrooms & Sleep
00:48:57 — Fibonacci Geometry, Cellular Voltage & Mitochondria
00:50:38 — Cleanses, Fasting & Glutathione
00:53:11 — Mental Health, Personal Tragedy & Resilience
00:56:58 — The Placebo Effect & Mind-Body Healing
00:58:57 — Rapid Fire: Sunlight, Frequency & Future Technologies
01:06:00 — Peptide Research: Follistatin, Klotho & Future Medicine
01:11:58 — Where to Find The Light System & Closing Remarks
Jarrod Barakett Instagram (@jarrod.barakett)
The Light System Website
The Light System Instagram (@thelight.system)
Books / Concepts / Researchers Mentioned
Dr. Masaru Emoto (water and intention research)
Fibonacci Sequence
Sacred Geometry
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight Labs:
BioLight:
Sep 3, 2026
Sep 3, 2026
36 min
In this special Research Jamboree episode of The Energy Code, Dr. Mike Belkowski takes listeners on a rapid-fire tour through some of the most exciting mitochondrial research published over the past few months. Rather than diving deeply into one paper, this episode highlights ten cutting-edge studies spanning environmental toxins, mitochondrial peptides, gut health, Alzheimer's disease, osteoporosis, cardiovascular health, sex differences in metabolism, and one of the most fascinating breakthroughs yet — transplanting a person's own mitochondria into their eyes in an attempt to restore vision.
Along the way, Dr. Mike explains what each study found, why it matters, where the science is headed, and what these discoveries reveal about the central role mitochondria play in virtually every aspect of human health. From glyphosate toxicity to Humanin, MOTS-c, Urolithin A, mitophagy, and the future of mitochondrial transplantation, this episode is packed with practical insights and exciting developments from the forefront of mitochondrial medicine.
(Educational content only, not medical advice.)
-
Articles Discussed in Episode:
-
The Gut Microbiome and Mitochondrial Function in Metabolism, Immunity, and Disease
-
Patient's Own Mitochondria Injected Into Eyes in Attempt to Restore Vision
-
Key Quotes From Dr. Mike:
"Roundup appears far more damaging to cardiac mitochondria than glyphosate by itself."
"Mitochondria are essential signaling hubs linking endocrine health, immune function, and metabolism."
"Mitochondrial dysfunction may be one of the primary drivers of neuroinflammation."
"Cholesterol may actually be acting as a compensatory response to mitochondrial stress."
"Lower Humanin and MOTS-c levels correlated with more severe atrial fibrosis."
"Mitophagy continues to emerge as one of the most important longevity pathways."
"Alzheimer's disease may be fueled by both mitophagy failure and calcium dysregulation."
"Scientists have now injected a patient's own mitochondria into the eye."
"Virtually every paper we discussed comes back to improving bioenergetics."
-
Key Points
⚡ This episode features a rapid-fire review of ten newly published mitochondrial research papers across multiple areas of health.
⚡ Commercial Roundup appears substantially more toxic to cardiac mitochondria than glyphosate alone, highlighting the importance of herbicide co-formulants.
⚡ Mitochondrial function differs significantly between men and women due to hormonal regulation throughout life.
⚡ Mitochondrial dysfunction may be a central driver of neuroinflammation and numerous neurological diseases.
⚡ Cholesterol may play a far more complex role in mitochondrial disease than previously appreciated.
⚡ Chinese botanical medicines may support osteoporosis by improving mitochondrial biogenesis, dynamics, and mitophagy.
⚡ Humanin and MOTS-c demonstrated promising effects in reducing atrial fibrosis and atrial fibrillation in preclinical research.
⚡ The gut microbiome may influence health primarily through its effects on mitochondrial resilience rather than microbial composition alone.
⚡ Urolithin A continues to demonstrate impressive mitophagy-promoting effects while improving heart function in heart failure models.
⚡ Alzheimer's disease progression appears closely linked to impaired mitophagy and disrupted calcium homeostasis.
⚡ Researchers successfully transplanted a patient's own mitochondria into the eye, demonstrating safety and temporary physiological improvements.
⚡ Mitochondrial transplantation could become one of the next major frontiers in regenerative medicine.
⚡ Throughout nearly every study, improved mitochondrial quality control, energy production, and bioenergetics emerged as common therapeutic themes.
-
Episode timeline
- Introduction: Research Jamboree Format
- BioLight Instagram Update & Free Speech Discussion
- Roundup vs. Glyphosate and Cardiac Mitochondria
- Sex Differences in Mitochondrial Function
- Mitochondria and Neuroinflammation
- Cholesterol's Role in Mitochondrial Disease
- Chinese Botanical Medicines & Osteoporosis
- Humanin + MOTS-c for Atrial Fibrillation
- Gut Microbiome & Mitochondrial Resilience
- Urolithin A for Heart Failure
- Mitophagy & Alzheimer's Disease
- Mitochondrial Transplantation to Restore Vision
- Final Thoughts & Future of Mitochondrial Medicine
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight Labs:
BioLight:
Aug 27, 2026
Aug 27, 2026
1 hr 3 min
Intranasal peptides have become one of the most exciting frontiers in peptide research — but which ones actually make sense, and why?
In this episode, Dr. Mike Belkowski breaks down the science behind 14 different intranasal peptide formulations, explaining how the nasal cavity may provide a unique pathway to the brain through the olfactory and trigeminal nerves while partially bypassing the blood-brain barrier.
From cognitive enhancement and stress resilience to mitochondrial function, neuroprotection, sleep, circadian biology, traumatic brain injury, neuroinflammation, and healthy brain aging, this episode explores the proposed mechanisms and emerging research behind today's most talked-about intranasal peptides.
Dr. Mike reviews the evidence behind Semax, Selank, SS-31, MOTS-c, Humanin, Epitalon, Pinealon, BPC-157, KPV, DSIP, Oxytocin, and three novel peptide blends while emphasizing where the science is strongest — and where it's still highly theoretical.
Whether you're interested in brain health, mitochondrial medicine, longevity, or peptide science, this episode serves as one of the most comprehensive overviews available on intranasal peptide research.
(Educational content only, not medical advice.)
-
Key Quotes From Dr. Mike:
"The nasal cavity provides one of the most unique access points we have to the central nervous system."
"Intranasal delivery isn't magic — but for the right peptide, it may dramatically change where that peptide goes."
"Semax is the accelerator, Selank is the stabilizer... One improves focus, the other improves calm."
"Humanin may be one of the most exciting mitochondrial-derived peptides for brain recovery."
"BPC-157 may be far more interesting for brain injury than most people realize."
"KPV isn't just an anti-inflammatory peptide — it may become a neuroinflammatory peptide."
"Oxytocin isn't simply the 'love hormone' — it's deeply involved in stress circuitry."
"Brain health is ultimately an energy problem before it becomes a disease problem."
-
Key Points
⚡ Intranasal peptide delivery may provide direct access to the central nervous system through the olfactory and trigeminal pathways while partially bypassing the blood-brain barrier.
⚡ Unlike oral peptides, intranasal delivery avoids gastrointestinal degradation and first-pass liver metabolism.
⚡ Not every peptide is suitable for intranasal delivery — molecular size, stability, formulation, and nasal absorption all influence effectiveness.
⚡ Semax remains one of the most extensively studied intranasal peptides for cognition, neuroplasticity, and neuroprotection.
⚡ Selank is primarily researched for anxiety reduction, stress resilience, calm focus, and GABA-related signaling.
⚡ Combining Semax and Selank may provide complementary support for focus, learning, emotional regulation, and stress resilience.
⚡ SS-31 targets cardiolipin within mitochondria, making it one of the most unique mitochondrial peptides for neuronal energy production.
⚡ MOTS-c supports metabolic adaptation, mitochondrial resilience, and recovery following neurological stress.
⚡ An SS-31 + MOTS-c blend may offer one of the strongest theoretical approaches for mitochondrial brain support.
⚡ Humanin restores mitochondrial bioenergetics and synaptic function following traumatic brain injury in preclinical research.
⚡ Epitalon primarily targets circadian biology, pineal signaling, and healthy aging rather than acute cognitive enhancement.
⚡ Pinealon focuses more directly on cognition, neuroprotection, and neuronal resilience.
⚡ Combining Epitalon with Pinealon creates a longevity-focused formulation targeting both circadian biology and cognitive aging.
⚡ BPC-157 may have intriguing applications for traumatic brain injury, vascular integrity, and neuronal recovery.
⚡ KPV appears particularly promising for neuroinflammation and microglial regulation.
⚡ DSIP centers around restorative sleep, stress recovery, hypoxia tolerance, and mitochondrial support.
⚡ Oxytocin has one of the largest bodies of intranasal research for stress regulation, PTSD, emotional processing, and social cognition.
⚡ Many of these proposed applications remain mechanistic or preclinical and require substantially more human clinical research.
⚡ Rather than targeting neurotransmitters alone, many of these peptides aim to improve mitochondrial function, cellular resilience, inflammation, and recovery.
⚡ The episode concludes with a practical framework that categorizes every peptide by its primary research focus — from repair and inflammation to focus, calm, mitochondrial resilience, and longevity.
-
Episode timeline
00:00 — Introduction: Why Intranasal Peptides?
04:30 — How Nose-to-Brain Delivery Works
07:15 — Semax
11:12 — Selank
15:00 — Semax + Selank
17:10 — SS-31
22:40 — MOTS-c
26:40 — SS-31 + MOTS-c
28:24 — Humanin
31:50 — Epitalon
35:08 — Pinealon
37:25 — Epitalon + Pinealon
39:18 — BPC-157
45:52 — KPV
48:28 — DSIP
53:27 — Oxytocin
57:06 — Final Review & Best Use Cases
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight Labs:
BioLight:
Aug 20, 2026
Aug 20, 2026
45 min
Could metabolic aging, chronic anxiety, and depression all share the same biological root?
In this episode of The Energy Code, Dr. Mike Belkowski reviews three newly published studies that, when viewed together, point toward an emerging concept he calls the mitochondria-metabolism-brain axis.
The first paper explores how GLP-1 medications may influence mitochondrial biology beyond weight loss by interacting with pathways involved in mitochondrial biogenesis, oxidative stress, and cellular resilience. The second investigates how Urolithin A restored mitophagy and eliminated anxiety-like behavior in animal models. The third demonstrates how Urolithin B improved depression-like behavior by activating mitochondrial quality-control pathways through SLP2 and the PINK1/Parkin signaling system.
While much of the evidence remains preclinical, the convergence across these independent research groups is striking.
Rather than focusing on three different diseases, the episode explores one shared biological thread: mitochondrial quality control.
If these findings continue to translate into humans, they could fundamentally reshape how we think about metabolism, aging, inflammation, resilience, and brain health.
(Educational content only, not medical advice.)
-
Articles Discussed in Episode:
The GLP-1–Mitochondria Axis in Metabolic Aging
-
Key Quotes From Dr. Mike:
"The real question isn't whether one of these compounds works — it's whether we're uncovering a broader mitochondria-metabolism-brain axis."
"Mitochondrial dysfunction sits at the center of metabolic aging."
"GLP-1 drugs may be touching the exact mitochondrial machinery that declines with age."
"Urolithin A didn't simply reduce anxiety — it appeared to restore the mitochondrial quality control system underlying it."
"Urolithin B improved behavior, protected hippocampal neurons, and reduced neuroinflammation."
"Mitochondrial quality control may be one of the shared nodes connecting metabolism, aging, inflammation, and the brain."
"The mitochondrion is beginning to look less like a power plant and more like a resilience hub."
-
Key Points
⚡ Three newly published studies explored metabolic aging, anxiety, and depression—but all converged on mitochondrial biology as a shared mechanism.
⚡ The episode introduces the emerging concept of the mitochondria-metabolism-brain axis.
⚡ A new Aging Cell review proposes that mitochondrial dysfunction sits at the center of metabolic aging.
⚡ Age-related declines in NAD, sirtuins, PGC-1α, mitochondrial biogenesis, and mitophagy may collectively drive metabolic decline.
⚡ GLP-1 receptor agonists may influence mitochondrial function through AMPK, PGC-1α, NRF2, and mitophagy pathways.
⚡ Despite compelling mechanisms, direct mitochondrial benefits of GLP-1 drugs in humans remain an active hypothesis—not established fact.
⚡ Large clinical trials continue to demonstrate significant cardiovascular and metabolic benefits from GLP-1 therapies.
⚡ Neurons have extraordinarily high energy demands, making the brain especially vulnerable to mitochondrial dysfunction.
⚡ A new Biological Psychiatry study found that Urolithin A eliminated anxiety-like behavior in multiple rodent models.
⚡ Urolithin A restored mitochondrial quality control by improving mitophagy through the PINK1/Parkin pathway.
⚡ The anti-anxiety effects occurred without sedation and primarily benefited animals exhibiting high anxiety.
⚡ Urolithin A also restored neuronal connectivity, dendritic complexity, synaptic function, and Mitofusin-2 expression.
⚡ A second study found that Urolithin B significantly improved depression-like behavior in stressed rats.
⚡ Urolithin B reduced neuroinflammation, preserved hippocampal neurons, increased BDNF and serotonin, and lowered corticosterone.
⚡ Researchers identified SLP2 as a key upstream regulator driving PINK1/Parkin-mediated mitophagy.
⚡ Knocking down SLP2 largely eliminated Urolithin B's protective effects, strengthening the proposed mechanism.
⚡ All three papers independently converged on mitochondrial quality control and mitophagy as central biological processes.
⚡ The PINK1/Parkin pathway appeared repeatedly across metabolic aging, anxiety, and depression research.
⚡ Mitochondrial quality control may represent a shared biological node linking seemingly unrelated chronic diseases.
⚡ The most important takeaway isn't any single molecule—it's the growing evidence that mitochondrial resilience may influence multiple organ systems simultaneously.
-
Episode timeline
00:00 – One Question Connects Three Diseases
-
Could metabolic aging, anxiety, and depression all share one biological mechanism?
02:30 – The GLP-1 Mitochondrial Axis
-
Aging Cell review
-
Mitochondrial dysfunction and metabolic aging
-
NAD, sirtuins, PGC-1α, mitophagy
-
Human vs. animal evidence
16:40 – Why the Brain Depends on Healthy Mitochondria
-
Neuronal energy demands
-
Why mitochondrial dysfunction disproportionately affects the brain
18:40 – Urolithin A and Anxiety
-
Biological Psychiatry study
-
Anxiety models
-
Mitophagy restoration
-
PINK1/Parkin pathway
-
Mitofusin-2
27:00 – Urolithin B and Depression
-
Brain Research Bulletin study
-
SLP2 signaling
-
PINK1/Parkin activation
-
Hippocampal neuroprotection
-
Behavioral improvements
36:30 – The Bigger Picture
-
How all three studies converge
-
The mitochondria-metabolism-brain axis
-
Why mitochondrial quality control may become one of the defining concepts in longevity science
41:30 – Final Takeaways
-
-
What we know
-
What remains speculative
-
Why this emerging field deserves close attention
-
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight Labs:
BioLight:
Aug 13, 2026
Aug 13, 2026
28 min
Every month there's an avalanche of new research — but very little of it actually changes how we think about health.
In this episode of The Energy Code, Dr. Mike Belkowski breaks down the most important mitochondrial research published over the last month and separates genuine scientific progress from marketing hype.
You'll learn why independent testing revealed that some commercial red light therapy devices don't emit the wavelengths they claim, why that matters far more than advertised power output, and what consumers should actually be looking for.
Dr. Mike also explores the latest mechanistic research on methylene blue, the expanding clinical evidence behind Urolithin A, and a fascinating new body of mitochondrial science suggesting that dysfunctional mitochondria may actively drive inflammation and aging through cellular signaling — not simply by producing less energy.
If the recent science is pointing in one direction, it's this:
Mitochondrial quality may be one of the most important upstream regulators of health, resilience, and longevity.
Whether you're interested in red light therapy, methylene blue, Urolithin A, or simply understanding where longevity science is headed next, this episode provides an evidence-based review of the month's biggest developments.
(Educational content only, not medical advice.)
-
Key Quotes From Dr. Mike:
"Wavelength is the identity of the treatment... Power output can often be compensated for. Wavelength cannot."
"Consumers should care whether companies are willing to have their products independently tested."
"Methylene blue is not a molecule where more automatically means better."
"Healthy mitochondria don't just make energy. They help determine how your cells respond to stress, inflammation, and aging."
"Every month, the science becomes a little clearer: mitochondrial health sits upstream of countless chronic diseases."
"The best longevity interventions don't replace biology — they help restore how biology was designed to function."
-
Key Points
⚡ Independent researchers tested commercial red light therapy devices with laboratory spectrometers and found that some failed to emit the wavelengths they claimed.
⚡ Wavelength accuracy may be more important than raw power output because wavelength determines the biological target being stimulated.
⚡ FDA Registered, FDA Cleared, and FDA Approved are very different regulatory classifications—and understanding the distinction matters.
⚡ The red light industry is beginning to mature, with manufacturers focusing more on wavelength selection and engineering than simply increasing wattage.
⚡ New mechanistic research continues strengthening our understanding of how methylene blue influences mitochondrial redox biology.
⚡ Methylene blue appears to provide its greatest mitochondrial benefits at lower doses, reinforcing its biphasic dose-response.
⚡ Safety remains paramount with methylene blue, particularly regarding serotonergic medications, dosing, and product purity.
⚡ Urolithin A continues expanding beyond muscle health into immune aging, obesity, cognition, oncology, and metabolic health.
⚡ A new Nature Aging study explored how Urolithin A may support immune function by improving mitochondrial quality control through mitophagy.
⚡ Researchers are now investigating whether Urolithin A can help preserve lean muscle mass during weight loss, particularly alongside GLP-1 therapies.
⚡ Emerging mitochondrial research suggests damaged mitochondria actively communicate with the nucleus, influencing inflammatory gene expression and aging.
⚡ Mitochondria are increasingly being viewed as drivers of inflammation — not simply victims of aging.
⚡ New research highlights the importance of mitochondrial membranes, network dynamics, and respiratory supercomplex architecture in maintaining cellular energy production.
⚡ Controlled mitochondrial stress (hormesis) continues to emerge as one of the body's most powerful mechanisms for building resilience.
⚡ The month's research reinforces that mitochondrial quality—not simply mitochondrial quantity — may be one of the most important upstream regulators of healthspan and longevity.
⚡ While supplements and therapies continue to advance, the highest-leverage mitochondrial interventions remain the fundamentals: quality nutrition, exercise, sleep, metabolic health, and consistent healthy habits.
⚡ Red light therapy, methylene blue, and Urolithin A should be viewed as tools that amplify a strong biological foundation — not replace one.
-
Episode timeline
00:00 – Why This Month Actually Matters
- The biggest red light story wasn't a new device—it was independent testing.
- Overview of the month's biggest mitochondrial research.
02:00 – Red Light Therapy Under the Spectrometer
- Independent wavelength verification.
- Why wavelength accuracy matters more than marketing wattage.
- Devices that passed—and those that didn't.
05:05 – FDA Marketing vs Reality
- FDA Registered vs FDA Cleared vs FDA Approved.
- Why consumers should understand the difference.
09:20 – Methylene Blue Update
- New mitochondrial mechanisms.
- Redox biology.
- Why dose remains everything.
14:30 – Urolithin A's Research Explosion
- Nature Aging publication.
- Immune aging.
- Muscle preservation during weight loss.
- Obesity and cognition research.
20:08 – The Biggest Story of the Month
- Mitochondria communicate with the nucleus.
- Inflammation and aging may begin upstream in mitochondrial dysfunction.
- Why this changes how we think about longevity.
22:50 – Practical Takeaways
- Choosing red light devices.
- Methylene blue expectations.
- Why Urolithin A continues gaining momentum.
- The importance of foundational lifestyle interventions.
26:45 – What's Coming Next
- Future red light testing.
- Traumatic brain injury research.
- Urolithin A clinical expansion.
- Mitochondrial signaling and epigenetics.
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight Labs:
BioLight:
Aug 6, 2026
Aug 6, 2026
1 hr 25 min
(Educational content only, not medical advice.)
Social Media
IG: @Celliant
Celliant
Original Source Collective (Coffee Company)
Discount code: BIOLIGHT15 for 15% off
Volap.io
Key Quotes From David Horinek
“Good for people and good for the planet has always been my mantra.”
“Nature is still one of the greatest technologies we’ve ever had.”
“The future of wellness is frequencies, energies, and intuition.”
“I don’t feel like I lived if I didn’t learn something new every day.”
“I try to create one hero moment every single day.”
Key Points
⚡ David Horinek returns to discuss the latest innovations he’s developing across biohacking, sustainable materials, and frequency-based health technologies.
⚡ Morning sunlight, grounding, and time in nature remain foundational health practices despite rapidly advancing wellness technologies.
⚡ Infrared-responsive materials continue expanding into clothing, bedding, topical products, agriculture, and construction materials.
⚡ Violet-light technologies may become a future tool for food preservation and biological applications.
⚡ David believes light, sound, and frequency therapies represent one of the next frontiers in health optimization.
⚡ The conversation explores how mitochondrial function and peptide production may be more closely connected than previously understood.
⚡ Emerging peptide delivery systems may reduce reliance on injectable therapies through improved absorption technologies.
⚡ AI and data centers present both opportunities and challenges, including concerns around energy use, noise pollution, infrastructure, and privacy.
⚡ David shares his philosophy on entrepreneurship, intellectual property, intuition, and developing inventions through collaboration.
⚡ Both David and Dr. Mike emphasize small daily habits, spending time outdoors, and continuous learning as long-term strategies for health and success.
⚡ The episode concludes with a rapid-fire Q&A covering David’s favorite inventions, biggest inspirations, and vision for the future of wellness.
Timeline
00:00:00–00:02:47 — Mike introduces David Horinek and the evolution of BioBlue and BioCream
00:02:48–00:06:02 — Morning sunlight, circadian biology, infrared energy, and David’s early influences
00:06:03–00:10:58 — Frequency agriculture, sustainable textiles, AI-assisted farming, and NASA-inspired research
00:10:59–00:15:00 — Building cellular homeostasis with light, sound, and mitochondrial support
00:15:01–00:18:00 — Red light therapy, eye health, nutrition, and daily longevity practices
00:18:01–00:22:48 — Grounding, forest immersion, and reconnecting with nature
00:22:49–00:25:50 — Chaga, sea buckthorn, functional nutrition, and BioCream
00:25:51–00:35:45 — Cold exposure, active building materials, BioLight innovations, and longevity technologies
00:35:46–00:45:56 — Functional beverages, women’s health products, future inventions, and entrepreneurial updates
00:45:57–00:49:10 — Intellectual property strategies, collaborative innovation, and violet-light food preservation technologies
00:49:11–00:54:30 — The future of peptides, blockchain applications, digital ownership, and decentralized technologies
00:54:31–01:04:38 — AI, data centers, sustainable infrastructure, meditation, float therapy, and creativity
01:04:39–01:12:17 — Mitochondria, peptide signaling, bioenergetics, photonic amino acids, and the future of frequency medicine
01:12:18–01:19:58 — Practitioner philosophy, resilience, daily habits, Kaizen, grounding, and peptide delivery innovations
01:19:59–01:23:31 — Rapid-fire questions: favorite inventions, wellness technologies, inspiration, and the future of health
01:23:32–End — Where to follow David, upcoming projects, final thoughts, and closing remarks
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight Labs:
BioLight:
Jul 30, 2026
Jul 30, 2026
1 hr 56 min
What does one of the world's most respected transformation coaches do to stay healthy while constantly traveling, competing, and pushing the limits of performance?
In this wide-ranging conversation, Dr. Mike Belkowski sits down with Kris Gethin to explore the practical side of biohacking — from travel optimization and circadian health to grounding, light exposure, peptides, longevity, and why intuition may be just as important as technology.
Chris shares his personal peptide journey, including how BPC-157, TB-500, GHK-Cu, and cartilage-targeting peptides dramatically accelerated his recovery after major injuries. He also discusses the current peptide landscape, how to identify reputable sources, and where he believes the industry is headed.
The conversation ultimately comes back to a simple but powerful message: the greatest health interventions are often the foundational ones — movement, sunlight, nature, sleep, and consistency.
(Educational content only, not medical advice.)
-
Articles & Books Discussed in Episode:
-
Books by Kris Gethin: 12-Week Daily Video Trainer, The Bodybuilding.com Guide to Your Best Body, and Man of Iron
-
Research & References: Peptide Signaling and Tissue Bioregulators Study, Environmental Psychology of View Angles and Cortisol Reduction, Methylene Blue Cellular Energy Research
-
Key Quotes From Kris:
-
“Health optimization requires continuous daily mobility, not just an intense hour in the gym.”
-
“If you over-quantify every single biological metric, you end up inducing the very stress you're trying to eliminate.”
-
“Grounding and nature offer a biological reset that no expensive technology can replicate.”
-
“Peptides provide the body with precise cellular directions, but sourcing and third-party testing are non-negotiable.”
-
“Sleep quality will always trump sleep duration if your environment isn't dialed in.”
-
Website & Other:
Unmatched Supps
Kris Gethin Coaching
Key Points
⚡ Kris Gethin joins Dr. Mike Belkowski for a treadmill-desk session focused on practical health optimization and high-performance recovery.
⚡ Continuous daily movement and mobility take precedence over isolated workout sessions for long-term metabolic health.
⚡ Combatting travel-induced oxidative stress requires proactive pre-, during-, and post-flight protocols.
⚡ Key travel non-negotiables include Faraday shielding, blue-light blocking glasses, and grounding techniques to maintain circadian balance.
⚡ Earth grounding and spending time in natural settings trigger immediate stress reduction and biological recovery.
⚡ Over-reliance on health tracking devices can cause "shiny object syndrome" and distract from listening to internal body cues.
⚡ Tissue-specific bioregulator peptides like BPC-157 and TB-500 aid in targeted cell signaling for injury recovery and repair.
⚡ The peptide industry faces significant hurdles with FDA scrutiny, payment processing issues, and gray-market quality concerns.
⚡ Independent, third-party lab testing is essential for consumers looking to verify peptide purity and authenticity.
⚡ Methylene blue serves as an effective intervention for enhancing cellular energy and mitochondrial function.
⚡ Optimizing sleep architecture relies on environmental controls like total blackout light elimination, air filtration, and active cooling.
⚡ Sleep duration matters far less than sleep quality and uninterrupted deep/REM cycles tailored to individual needs.
-
Episode Timeline
-
00:00:02–00:00:34 — Show Intro: Unlocking the Mitochondrial Matrix
-
00:00:35–00:03:00 — Welcome back Kris Gethin & treadmill desk catch-up
-
00:03:01–00:04:09 — The importance of continuous daily movement over isolated workouts
-
00:04:10–00:07:10 — Authenticity and mentorship in the health and wellness industry
-
00:07:11–00:13:14 — Pre-, during-, and post-travel protocols to mitigate oxidative stress and jet lag
-
00:13:15–00:16:48 — Mid-episode spotlight: Methylene blue and cellular energy boost
-
00:16:49–00:17:59 — Top 3 travel non-negotiables: Faraday blankets, grounding footwear, and blue-blocking glasses
-
00:18:00–00:22:24 — The overlooked biological power of earthing and grounding
-
00:22:25–00:28:16 — Nature as nurturing medicine: Environmental psychology and view angles
-
00:28:17–00:32:14 — Sifting through biohacking noise: Fraud, over-testing, and shiny object syndrome
-
00:32:15–00:37:59 — Balancing data quantification with intuitive bodily awareness
-
00:38:00–00:43:42 — Deep dive into peptides: Origins, injury recovery, and tissue regeneration
-
00:43:43–00:47:31 — Industry challenges: Payment processing, FDA scrutiny, and gray market quality control
-
00:47:32–00:52:11 — Consumer advice for sourcing peptides and performing independent lab testing
-
00:52:12–01:02:44 — Comparing peptides to traditional pharmaceuticals and life-extending signaling
-
01:02:45–01:04:59 — Emerging peptides: Klotho proteins, myostatin inhibitors, and new delivery methods
-
01:05:00–01:12:01 — Analysis of extreme health tracking and avoiding performance anxiety in biohacking
-
01:12:02–01:17:22 — Upgrading sleep architecture: Blackout shades, Chilly Pad temperature control, and air filtration
-
01:17:23–01:20:06 — Sleep hours vs. sleep quality: Individualized sleep architecture
-
01:20:07–01:25:30 — Unmatched Longevity Sleep: Ingredient synergies and supporting natural sleep hygiene
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight Labs:
BioLight:
Jul 27, 2026
Jul 27, 2026
25 min
Something significant just happened in the world of peptides.
On July 23–24, the FDA’s Pharmacy Compounding Advisory Committee considered seven widely discussed peptides and voted in favor of six: BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax, while rejecting DSIP (emideltide).
But these votes are widely misunderstood.
In this Energy Code Deep Dive, Dr. Mike Belkowski breaks down what the committee actually voted on, why a YES vote is not FDA drug approval, and the debate that divided the committee: should promising but under-studied peptides remain largely in the gray market, or could regulated pharmacy compounding provide a safer path?
We explore the harm-reduction argument behind the YES votes, the FDA scientists’ objections, concerns surrounding human evidence, product consistency and immunogenicity, why DSIP failed to clear the bar, and what happens next.
This isn't the finish line for peptides. But it could represent a major turning point in how peptide medicine is researched, regulated, and ultimately accessed.
(Educational content only, not medical advice.)
-
Key Quotes From Dr. Mike:
“Six of the seven (peptides) got a thumbs up. One got rejected.”
“A yes vote didn't mean the FDA is declaring the peptide safe and effective.”
“The yes side is saying, ‘Meet people where they are and add safety guardrails.’”
“The no side says, ‘Thin evidence is thin evidence, and a regulatory blessing shouldn't get ahead of the science.’”
“The single best thing that could come out of this moment is that the mainstreaming of peptides drives real rigorous clinical research.”
-
Key Points
⚡ An FDA advisory committee voted favorably on 6 of 7 peptides considered for the 503A compounding pathway.
⚡ BPC-157, KPV, TB-500, MOTS-c, Epitalon, and Semax received favorable recommendations; DSIP did not.
⚡ These votes do not constitute FDA drug approval and are non-binding recommendations.
⚡ One of the strongest arguments for inclusion was harm reduction: moving peptide use away from unregulated gray-market sources and toward clinicians and licensed pharmacies.
⚡ FDA scientists opposed inclusion, citing limited human evidence, product-characterization issues, immunogenicity concerns, and the possibility of creating false perceptions of FDA endorsement.
⚡ The BPC-157 vote was particularly close: 8–6 with one abstention.
⚡ DSIP was rejected amid especially limited evidence and questions surrounding the proposed route of administration.
⚡ The composition of the advisory committee and potential industry conflicts became another source of controversy.
⚡ Even if ultimately permitted for compounding, these products would remain fundamentally different from FDA-approved drugs.
⚡ The larger opportunity may be increased legitimacy driving better human clinical research into peptides.
-
Episode timeline
00:00 — A major moment for peptide medicine
Why the July FDA advisory committee meeting deserves attention.
01:28 — What the FDA actually voted on
The crucial difference between FDA drug approval and inclusion on the compounding bulks list.
04:20 — Nothing changed overnight
Why the committee's recommendations are non-binding and what happens next.
04:55 — Peptides 101 & the gray-market problem
Why peptide popularity has outpaced human clinical evidence and regulation.
06:27 — The final tally: 6 YES, 1 NO
BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax versus DSIP.
08:12 — Breaking down the six peptides
What each peptide is commonly associated with and why they're attracting attention.
10:05 — Why the YES side won
The central harm-reduction argument: people are already using peptides, so would regulated access be safer?
12:17 — Why FDA scientists opposed all seven
Human evidence, consistency, immunogenicity and the danger of perceived regulatory endorsement.
15:15 — Why DSIP failed
What the committee's lone rejection reveals about its evidentiary threshold.
16:45 — Politics & conflicts of interest
The political environment surrounding the meeting and questions about the panel's composition.
18:52 — What this means for consumers right now
Why these votes do not suddenly make the peptides FDA-approved or broadly legal.
20:39 — A legitimacy inflection point
Why peptide medicine may be transitioning from a fringe conversation toward the mainstream.
21:15 — The research opportunity
Why regulatory momentum still cannot substitute for rigorous human clinical trials.
22:19 — Final takeaways
Why this is the beginning of the peptide conversation—not the finish line.
-
Dr. Mike's #1 recommendations:
Deuterium depleted water: Litewater (code: DRMIKE)
EMF-mitigating products: Somavedic (code: BIOLIGHT)
Blue light blocking glasses: Ra Optics (code: BIOLIGHT)
Grounding products: Earthing.com
-
Stay up-to-date on social media:
Dr. Mike Belkowski:
BioLight Labs:
BioLight: